Published in Int J Prev Med on March 01, 2014
Systolic Blood Pressure Intervention Trial (SPRINT) | NCT01206062
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA (2003) 13.82
Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med (2006) 9.40
Underdiagnosis of hypertension in children and adolescents. JAMA (2007) 5.41
Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr (2007) 4.63
A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med (2008) 4.61
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation (2007) 4.36
Trends in blood pressure among children and adolescents. JAMA (2004) 4.03
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol (2002) 3.37
Obesity hypertension in children: a problem of epidemic proportions. Hypertension (2002) 3.30
Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens (1995) 3.07
Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation (2007) 2.50
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension (2010) 2.47
Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens (2009) 2.20
Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension (2012) 2.19
Is prehypertension a risk factor for cardiovascular diseases? Stroke (2005) 2.14
Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation (2005) 1.98
The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr (2006) 1.51
Trial of preventing hypertension: design and 2-year progress report. Hypertension (2004) 1.48
Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics (2008) 1.35
Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study. Am J Hypertens (2004) 1.24
Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich) (2004) 1.16
Tracking of systolic blood pressure during childhood: a 15-year follow-up population-based family study in eastern Finland. J Hypertens (2002) 1.12
Psychosocial factors and progression from prehypertension to hypertension or coronary heart disease. Ann Fam Med (2007) 1.04
Obesity hypertension in adolescents: epidemiology, evaluation, and management. J Clin Hypertens (Greenwich) (2011) 0.99
Measuring children's blood pressure matters. Circulation (2008) 0.97
Progression of prehypertension to hypertension in adolescents. Curr Hypertens Rep (2012) 0.96
Strategies to reduce the incidence of chronic kidney disease in children: time for action. J Nephrol (2013) 0.95
Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol (2007) 0.95
Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol (2007) 0.92
Prehypertension in adolescents: risk and progression. J Clin Hypertens (Greenwich) (2012) 0.91
The growing epidemic of hypertension among children and adolescents: a challenging road ahead. Pediatr Cardiol (2012) 0.86
Hyperuricemia and hypertension. Adv Chronic Kidney Dis (2012) 0.83
Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension. J Nephrol (2013) 0.83